8-K: Clorox Q2 FY26 Results: Sales Dip, Outlook Confirmed

Clorox reported a 1% net sales decrease and a 16% diluted EPS drop for Q2 FY2026, while reaffirming its full-year outlook.

Summary

• Net sales decreased 1% to $1.67 billion in Q2 FY2026, primarily driven by lower consumption.
• Organic sales decreased 1% in Q2 FY2026.
• Gross margin decreased 60 basis points to 43.2% from 43.8% in the year-ago quarter, mainly due to higher manufacturing and logistics costs.
• Diluted net earnings per share (diluted EPS) decreased 16% to $1.29 from $1.54 in the year-ago quarter.
• Adjusted EPS decreased 10% to $1.39 from $1.55 in the year-ago quarter.
• Year-to-date net cash provided by operations was $404 million, a 1% increase compared to the year-ago period.
• The company reaffirmed its full-year fiscal year 2026 outlook, expecting net sales to be down 6% to 10% and organic sales to decrease 5% to 9%.
• Full-year fiscal year 2026 gross margin is still expected to be down 50 to 100 basis points.
• Full-year fiscal year 2026 diluted EPS is expected to be between $5.60 and $5.95, and adjusted EPS between $5.95 and $6.30.
• The outlook does not include the impact from the recently announced acquisition of GOJO Industries, expected to close before the end of fiscal year 2026.
• A significant transitory impact from the reversal of incremental shipments related to the ERP transition in the prior year is expected to reduce fiscal year 2026 sales by about 7.5 points and EPS by approximately 90 cents.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral to slightly negative report, with declining sales and EPS offset by strategic acquisitions and the completion of a major ERP implementation, aligning with prior expectations despite challenges.

Positives

• Entered into a definitive agreement to acquire GOJO Industries, adding Purell to its portfolio and expanding its leadership in health and hygiene.
• Successfully completed the final phase of its U.S. ERP implementation in January, marking a major milestone in its digital transformation.
• Introduced new products across its portfolio, including Clorox PURE, expanded Clorox Scentiva Bleach offerings, Glad's liquid-locking ForceFlex MaxStrength LeakGuard Trash Bags, and Burt's Bees Lip Butter and Lip Oil.
• Named among America's Most Responsible Companies in 2026 by Newsweek.
• International segment net sales increased 7% and segment adjusted EBIT increased 48%.
• Lifestyle segment adjusted EBIT increased 3%, primarily due to lower advertising investments.

Negatives

• Net sales decreased 1% to $1.67 billion in Q2 FY2026, primarily driven by lower consumption.
• Organic sales decreased 1% in Q2 FY2026.
• Gross margin decreased 60 basis points to 43.2%, primarily due to higher manufacturing and logistics costs.
• Diluted EPS decreased 16% to $1.29, including the impact of lapping cyberattack insurance recoveries from the prior period.
• Adjusted EPS decreased 10% to $1.39, primarily due to lapping tax rate benefits in the prior period and lower gross profit.
• Household segment net sales decreased 6% and segment adjusted EBIT decreased 54%, mainly due to lower consumption, unfavorable price mix, and higher manufacturing and logistics costs.
• Lifestyle segment net sales decreased 5%, primarily due to lower consumption.
• The full-year outlook, while reaffirmed, is expected to be at the lower end of the range due to order fulfillment challenges and market share losses experienced earlier in the year.
• The reversal of incremental shipments associated with the ERP transition in the prior fiscal year is expected to result in about 7.5 points of sales decline and reduce fiscal year 2026 diluted EPS by about 30% and adjusted EPS by about 23% compared to fiscal year 2025.

Risks

• Occurrence of any event, change, or other circumstance that could give rise to the termination of the GOJO acquisition agreement.
• The risk that the conditions to the completion of the proposed GOJO acquisition (including regulatory approval) are not satisfied in a timely manner or at all.
• Risks arising from the integration of the GOJO business.
• The uncertainty of rating agency actions related to the GOJO acquisition.
• The risk that the anticipated benefits and synergies of the proposed GOJO acquisition may not be realized when expected or at all.
• The risk that the proposed GOJO acquisition may not be completed in a timely manner or at all.
• The risk of unexpected costs or expenses resulting from the proposed GOJO acquisition, including the costs of financing.
• The risk of litigation related to the proposed GOJO acquisition, including resulting expense or delay.
• Risks related to disruption to ongoing business operations of the company and GOJO and diversion of time of management as a result of the proposed acquisition.
• The risk that the proposed GOJO acquisition may have an adverse effect on the ability of the company and GOJO to retain key personnel, customers, and suppliers.
• The risk that the credit ratings of the company decline following the proposed GOJO acquisition.
• The risk that the announcement or the consummation of the proposed GOJO acquisition has a negative effect on the market price of the common stock of the company or on the company's or GOJO's operating results.
• Unfavorable general economic and geopolitical conditions beyond our control, including inflation, supply chain disruptions, labor shortages, wage pressures, fuel and energy costs, interest rate fluctuations, foreign currency exchange rate fluctuations, weather events or natural disasters, disease outbreaks or pandemics, terrorism, and unstable geopolitical conditions.
• The impact of market and category declines, and the company's product and geographic mix on its ability to meet sales growth targets.
• The company's ability to successfully execute or realize the anticipated benefits of its strategic or transformational initiatives, including the ERP transition and the related timing and volume of shipment movement.
• The impact of the changing retail environment, including the growth of alternative retail channels and business models, and changing consumer preferences.
• Intense competition in the company's markets.
• Volatility and increases in the costs of raw materials, energy, transportation, labor, and other necessary supplies or services.
• Risks related to supply chain issues, product shortages, and disruptions to the business, as a result of increased supply chain dependencies due to an expanded supplier network and a reliance on certain single-source suppliers.
• Risks related to the company's use of and reliance on information technology systems, including potential and actual security breaches, cyberattacks, privacy breaches or data breaches.
• The ability of the company to innovate and to develop and introduce commercially successful products, or expand into adjacent categories and countries.
• The ability of the company to successfully manage global political, legal, tax, and regulatory risks, including due to regulatory uncertainty and lack of regulatory convergence among different jurisdictions.
• Lower revenue, increased costs, other financial statement impacts or reputational harm resulting from government actions, compliance with regulations, or any material costs imposed by changes in regulation.
• The company's ability to maintain its business reputation and the reputation of its brands and products.
• Dependence on key customers and risks related to customer consolidation and ordering patterns.
• The company's ability to attract and retain key personnel, which may continue to be impacted by challenges in the labor market, such as increasing labor costs and sustained labor shortages.
• Changes to our processes and procedures as a result of our digital capabilities and productivity enhancements that may result in changes to the company's internal controls over financial reporting.
• Risks related to international operations and international trade, including changing macroeconomic conditions, foreign currency fluctuations, changes in governmental policies, labor claims and civil unrest, and potential operational or supply chain disruptions from wars and military conflicts.
• Potential negative impact and liabilities from the use, storage, and transportation of chlorine in certain international markets where chlorine is used in the production of bleach.
• The impact of climate change and other sustainability issues on sales, operating costs, reputation or stakeholder relationships.
• The impact of product liability claims, labor claims, and other legal, governmental or tax proceedings, including in foreign jurisdictions and in connection with any product recalls.
• Risks relating to acquisitions, new ventures, and divestitures, and associated costs, including for asset impairment charges related to, among others, intangible assets, including trademarks and goodwill.
• The accuracy of the company's estimates and assumptions on which its financial projections, including any sales or earnings guidance or outlook it may provide from time to time, are based.
• Risks related to our reliance on third-party service providers, including inability to meet cost savings or efficiencies, business or systems disruptions, and other liabilities, including legal or regulatory risk.
• Environmental matters, including costs associated with the remediation and monitoring of past contamination, and possible increases in costs resulting from actions by relevant regulators, and the handling and/or transportation of hazardous substances.
• The company's ability to effectively utilize, assert and defend its intellectual property rights, and any infringement or claimed infringement by the company of third-party intellectual property rights.
• The effect of the company's indebtedness and credit rating on its business operations and financial results and the company's ability to access capital markets and other funding sources, as well as the cost of capital to the company.
• The company's ability to pay and declare dividends or repurchase its stock in the future.
• The impacts of potential stockholder activism.

Future Outlook

The company is maintaining its full-year fiscal year 2026 outlook for net sales, gross margin, and adjusted EPS, but expects results to be at the lower end of the range due to order fulfillment challenges and market share losses experienced earlier in the year. This outlook does not include the impact of the GOJO Industries acquisition, which is expected to close before the end of fiscal year 2026. A significant transitory driver for the fiscal year 2026 outlook is the reversal of incremental shipments from the prior year's ERP transition, which is expected to reduce sales by about 7.5 points and EPS by approximately 90 cents.

Management Comments

• "Our second-quarter results were generally in line with our expectations and reflect continued progress against our strategic priorities."
• "These results support our ability to reaffirm our fiscal year outlook in what remains a challenging and volatile environment."
• "We remain laser-focused on executing our back-half plans, supported by a strong slate of innovation and investments."
• "At the same time, we are advancing our transformation and are excited to expand our leadership position in health and hygiene through our recently announced acquisition of GOJO Industries."
• "We are well positioned to deliver more consistent, profitable growth and long-term shareholder value."

Industry Context

StockSavvy.ai notes that Clorox's strategic acquisition of GOJO Industries (Purell) positions it to capitalize on the enduring demand for health and hygiene products, a trend amplified by recent global events. The broader consumer goods sector continues to navigate inflationary pressures, supply chain complexities, and evolving consumer preferences, which are reflected in Clorox's mixed segment performance and cautious full-year outlook.

Stakeholder Impact

• Shareholders: Potential for long-term value creation from the GOJO acquisition and digital transformation, but short-term headwinds from declining sales, EPS, and the transitory ERP inventory drawdown impact.
• Customers: Benefit from new product introductions and an expanded health and hygiene portfolio (Purell); potential for improved service and product availability post-ERP implementation.
• Employees: Digital transformation and productivity enhancements may lead to operational changes; the GOJO acquisition will involve integrating new teams and talent.
• Suppliers: Continued exposure to volatility in raw material, energy, transportation, and labor costs, as well as supply chain disruptions.

Next Steps

• Execute back-half plans, supported by a strong slate of innovation and investments.
• Advance transformation initiatives, including digital capabilities and productivity enhancements.
• Close the acquisition of GOJO Industries before the end of fiscal year 2026.
• Host a live Q&A audio webcast with Chair and CEO Linda Rendle and Chief Financial Officer Luc Bellet to discuss the results.

Key Dates

Recommendation

The company's Q2 results show a decline in sales and EPS, but these were largely anticipated and led to a reaffirmation of the full-year outlook, albeit at the lower end. The strategic acquisition of GOJO Industries and the completion of the ERP implementation are positive long-term moves. However, the significant transitory impact from the ERP inventory drawdown on FY2026 earnings, coupled with ongoing challenging and volatile market conditions, suggests a 'hold' position until the benefits of the acquisition and transformation initiatives become clearer and the transitory headwinds subside.

Keywords

Clorox, CLX, Q2 2026, financial results, earnings, net sales, gross margin, EPS, GOJO Industries, Purell, acquisition, ERP implementation, digital transformation, consumer goods, health and hygiene, household products, international sales, fiscal year outlook, risk factors